Skip to main content
MIST
NASDAQ Life Sciences

EMA MAA Filed, Partner's China NDA Accepted for Milestone Pharma Product; Q1 Loss Reported

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.65
Mkt Cap
$202.388M
52W Low
$1
52W High
$3.06
52W Position info
65% above low
Off High info
46% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

MIST sits 65% above its 52-week low of $1 on elevated volume (2.6× avg).

Summary

Milestone Pharmaceuticals announced significant regulatory progress with the filing of a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) and the acceptance of a New Drug Application (NDA) in China for a partnered product. This marks crucial steps towards potential commercialization in key global markets. Concurrently, the company reported a Q1 net loss of $26.1 million and reiterated details of a previously filed $300 million universal shelf registration and $100 million at-the-market offering. While the regulatory advancements are positive catalysts, the Q1 financial results and potential dilution from the financing appear to have driven a negative market reaction, with shares falling approximately 11% premarket. Investors will now focus on the timelines for regulatory decisions and the company's financial performance.

At the time of this announcement, MIST was trading at $1.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $202.4M. The 52-week trading range was $1.00 to $3.06. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

MIST - Latest Insights

MIST
Oct 28, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.755349
Real-time Price: $0.6941 info
Change: -$0.061249 (-8%) info
Market Cap: $86.215M info
MIST
Sep 03, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.21
Real-time Price: $0.6941 info
Change: -$0.5159 (-43%) info
Market Cap: $86.215M info
MIST
Sep 03, 2026, 10:47 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $0.6941 info
Change: -$0.535 (-44%) info
Market Cap: $86.215M info
MIST
Aug 21, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.06
Real-time Price: $0.6941 info
Change: -$0.3659 (-35%) info
Market Cap: $86.215M info
MIST
Aug 12, 2026, 7:28 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.10
Real-time Price: $0.6941 info
Change: -$0.4059 (-37%) info
Market Cap: $86.215M info